Visit COVID-19 resources

[Skip to Content]

Report of 12-months efficacy and safety of intravitreal fluocinalone acetonide implant for the treatment of chronic diabetic macular oedema: a real-world result in the United Kingdom – (Eye Journal AOP)

20 January 2017

This news item is available to RCOphth members only, please log in below to access.

Members Login